Literature DB >> 20486727

Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements.

Merel M Tielemans1, Ties Eikendal, Jan B M J Jansen, Martijn G H van Oijen.   

Abstract

NSAIDs are among the most often used drugs worldwide. Numerous NSAID users are at risk for developing gastrointestinal complications. The purpose of this review was to identify and stratify risk factors for gastrointestinal complications in NSAID users documented in guidelines and consensus agreements, and to collect recommendations regarding over-the-counter (OTC) NSAID use. To facilitate this, a PubMed search from 1 January 1999 until 1 March 2009 was performed, resulting in the inclusion of nine English-language guidelines in our analysis. Risk factors were defined as 'definite' if mentioned in all guidelines; otherwise they were defined as 'controversial' risk factors. 'Definite' risk factors were a history of (complicated) peptic ulcer disease, older age (cut-off range 60-75 years), concomitant anticoagulant or corticosteroid use and multiple NSAID use, including low-dose aspirin (acetylsalicylic acid). 'Controversial' risk factors were high-dose NSAID use, concomitant clopidogrel or selective serotonin reuptake inhibitor use, a history of gastrointestinal symptoms, rheumatoid arthritis disability and cardiovascular disease. Infection with Helicobacter pylori was identified as an additive risk factor. Risk factors in OTC NSAID users were difficult to identify in the current literature. Risk factors were not all uniformly present in analysed guidelines and consensus agreements. We identified a history of (complicated) peptic ulcer disease, older age, concomitant anticoagulant or corticosteroid use and multiple NSAID use, including low-dose aspirin, as definite gastrointestinal risk factors in NSAID users.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486727     DOI: 10.2165/11534590-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  46 in total

Review 1.  Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs.

Authors:  S Hernández-Díaz; L A García-Rodríguez
Journal:  Am J Med       Date:  2001-02-19       Impact factor: 4.965

2.  Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.

Authors:  C Mel Wilcox; Jeroan Allison; Keith Benzuly; Marie Borum; Byron Cryer; Tilo Grosser; Richard Hunt; Uri Ladabaum; Angel Lanas; Harold Paulus; Carol Regueiro; Robert S Sandler; Lee Simon
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-31       Impact factor: 11.382

3.  Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

Authors:  Francis K L Chan; K F To; Justin C Y Wu; M Y Yung; W K Leung; Timothy Kwok; Y Hui; Henry L Y Chan; Cynthia S Y Chan; Elsie Hui; Jean Woo; Joseph J Y Sung
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

4.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

5.  Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.

Authors:  James D Lewis; Stephen E Kimmel; A Russell Localio; David C Metz; John T Farrar; Lisa Nessel; Colleen Brensinger; Karen McGibney; Brian L Strom
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

6.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Authors:  Francis K L Chan; Jessica Y L Ching; Lawrence C T Hung; Vincent W S Wong; Vincent K S Leung; Nelson N S Kung; Aric J Hui; Justin C Y Wu; Wai K Leung; Vivian W Y Lee; Kenneth K C Lee; Yuk T Lee; James Y W Lau; Ka F To; Henry L Y Chan; S C Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

Review 7.  Toxicity of NSAIDs in the stomach and duodenum.

Authors:  A Lanas; B I Hirschowitz
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-04       Impact factor: 2.566

8.  Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Authors:  Francis K L Chan; Neena S Abraham; James M Scheiman; Loren Laine
Journal:  Am J Gastroenterol       Date:  2008-10-01       Impact factor: 10.864

Review 9.  Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.

Authors:  Roger Jones; Greg Rubin; Francis Berenbaum; James Scheiman
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

10.  Reasons for the use of mild analgesics among English students.

Authors:  David P French; Delyth H James
Journal:  Pharm World Sci       Date:  2007-07-27
View more
  9 in total

1.  The clinical implications of heterotopic ossification in patients treated with radial head replacement for trauma: A case series and review of the literature.

Authors:  Seth H Bowman; William R Barfield; Harris S Slone; Gerald J Shealy; Zeke J Walton
Journal:  J Orthop       Date:  2016-06-28

2.  Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation.

Authors:  David Y Graham; Nicholas P Jewell; Francis K L Chan
Journal:  Am J Med Sci       Date:  2011-11       Impact factor: 2.378

3.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

4.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

5.  Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.

Authors:  Nicolette L de Groot; Matthijs P Hagenaars; Hugo M Smeets; Ewout W Steyerberg; Peter D Siersema; Martijn G H van Oijen
Journal:  J Gastroenterol       Date:  2013-04-23       Impact factor: 7.527

Review 6.  [DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain].

Authors:  W W Bolten; K Krüger; S Reiter-Niesert; D O Stichtenoth
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

7.  [Managing of the patient with dyspepsia. Clinical Practice Guideline. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet Calvo; Juan Ferrándiz Santos; Juan José Mascort Roca; Pablo Alonso-Coello; Mercè Marzo Castillejo
Journal:  Aten Primaria       Date:  2012-10-22       Impact factor: 1.137

8.  Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Meng-Tse Gabriel Lee; Chih-Cheng Lai; I-Lin Wu; Yi-Wen Tsai; Shy-Shin Chang; Chien-Chang Lee
Journal:  BMC Pulm Med       Date:  2017-05-04       Impact factor: 3.317

9.  Polypharmacy and Potential Drug-Drug Interactions in Home-Dwelling Older People - A Cross-Sectional Study.

Authors:  Monica Hermann; Nina Carstens; Lars Kvinge; Astrid Fjell; Marianne Wennersberg; Kjersti Folleso; Knut Skaug; Ake Seiger; Berit Seiger Cronfalk; Anne-Marie Bostrom
Journal:  J Multidiscip Healthc       Date:  2021-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.